Policy: Regulate Embryos Made for Research
By Insoo Hyun,
Nature
| 04. 28. 2014
Three independent research teams have now used cloning technology to make human embryonic stem cells carrying the genomes of existing people. The first announcement, using genomes from fetal and infant cells, came last year1. The next two reports have emerged in the past month, detailing human embryonic stem cells that were custom made from cell samples derived from living adults, including a 75-year-old man2 and a 32-year-old woman with type 1 diabetes3.
This repeated cloning of embryos and generation of stem cells, now using cells collected from adults, increases the likelihood that human embryos will be produced to generate therapy for a specific individual. The creation of more human embryos for scientific experiments is certain. Regulatory structures must be in place to oversee it.
These accomplishments were made possible by numerous tweaks, and by mastery of difficult techniques and of the administrative work required to collect enough eggs from healthy young women. Each research team inserted nuclei taken from human skin cells into unfertilized eggs from which the original nuclei had been removed. These constructions...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...